Funded Tech Companies

PharmaCyte Biotech

Headquartered in Las Vegas, PharmaCyte Biotech is venture-backed, with investment from private investors.

Company Overview

Company Name
PharmaCyte Biotech
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
3960 Howard Hughes Parkway 500
Las Vegas, NV 89169
USA
Email Address

Company Background Information

Overview
PharmaCyte is a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box, for potential development of cellular therapies for cancer, diabetes and malignant ascites. PharmaCyte's candidate therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or "cancer-killing" form. For pancreatic cancer, these encapsulated cells are to be implanted in the blood supply to the patient's tumor as close as possible to the site of the tumor. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) will be given intravenously at one-third the normal dose.
Profile
PharmaCyte Biotech LinkedIn Company Profile
Social Media
PharmaCyte Biotech Company Twitter Account
Company News
PharmaCyte Biotech News
Facebook
PharmaCyte Biotech on Facebook
YouTube
PharmaCyte Biotech on YouTube
Last Transaction
9/2/2025

Financing History

Date
Type
Amount
Venture Equity
$3,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Joshua Silverman
  Joshua Silverman LinkedIn Profile  Joshua Silverman Twitter Account  Joshua Silverman News  Joshua Silverman on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Pharmacy Marketplace | PharmAdva

     

    Share this article

     


    About Our Venture Capital Database

    This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary